“…Importantly, investigators have performed LCM on the Nissl-stained tissue itself [43, 208, 350, 390], but in principle, one can also use adjacent sections stained for Nissl substance to help delineate regions of interest on unstained companion sections sampled by LCM, as has been done for human tissue samples collected post mortem for the PVH and SO [451]. In addition to using Nissl staining as a tool to help delineate LCM-captured tissue sample boundary conditions, other stains and labeling strategies have also been used in conjunction with LCM, including FluoroJade for delimiting tissue pathology [43], Cy3-conjugated secondary antibody to identify antibody-labeled peptidergic neurons [302–304], immunoperoxidase-based detection of peptidergic neurons [47], NeuroTrace staining for visualizing fluorescent Nissl-like profiles [31], and in situ hybridization in human post mortem tissue [33]. Finally, it is worth noting that although LCM procedures themselves do not appear to result in significant losses of protein as compared to manually dissected samples of comparably located regions, Nissl staining itself can be detrimental to the full retention of some proteins for subsequent proteomic analyses [290], and the use of Nissl stains such as neutral red, cresyl violet, or NeuroTrace reportedly contributes to lower yields of transcripts from LCM-captured brain tissue [31, 213].…”